Immucell share price logo

Immucell

NASDAQ: ICCC

$9.75

+0.15

(+1.56%)

as on

Immucell Stock Performance

as on October 3, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $9.61
    $9.80
    downward going graph

    1.44%

    Downside

    0.51%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.52
    $12.10
    downward going graph

    53.64%

    Downside

    24.10%

    Upside

    downward going graph

Immucell share price movements today

Previous Close
$9.60
Open
$9.80
Volume
88.2K
Market Cap
$89.0M
Day's Low - High
$9.61 - $9.80
52 Week Low - High
$4.52 - $12.10

Immucell Historical Returns

1 Month Return
-4 %
3 Month Return
-6.71 %
1 Year Return
+ 46.56 %
3 Year Return
+ 83.21 %
5 Year Return
+ 5.49 %

Immucell Stock Fundamentals & Key Indicators

Check Immucell market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$89.0M

EPS (TTM)

0.0846

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

2.60%

PE Ratio (TTM)

115.84

Industry PE ratio

-2.26

PEG Ratio

-0.30

EBITDA

3.5M

Revenue (TTM)

30.7M

Profit Margin

40.32%

Return On Equity TTM

2.68%

Immucell vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immucell with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Immucell image
Immucell
Buy$89.0M5.49%115.8440.32%0.00%
Revolution Medicines image
Revolution Medicines
StrongBuy$44.1B609.62%-23.340.00%0.00%
Moderna image
Moderna
Neutral$75.4B-44.29%-24.08-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$132.5B180.98%30.1986.04%0.00%
Regeneron image
Regeneron
Buy$78.1B28.80%17.6784.86%0.50%

Stock Returns calculator for Immucell Stock including INR - Dollar returns

The Immucell stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immucell investment value today

Current value as on today

₹1,61,545

Returns

₹61,545

(+61.55%)

Returns from Immucell Stock

₹48,855 (+48.85%)

Dollar Impact

₹12,690 (+12.69%)

Analyst Recommendation on Immucell Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Immucell. Average target price of $14

Immucell Share Price Target

Get share price movements and forecasts by analysts on Immucell.

What analysts predicted

30.36%UPSIDE

Target Price

$14

Current Price

$9.75

Analyzed by

7 Analysts

Target

$14.00

Immucell target price $14, a slight upside of 30.36% compared to current price of $9.75. According to 7 analysts rating.

Indian Investors' Interest in Immucell Stock

Search interest for Immucell Stock has increased by 220% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:220% versus previous 30 day period

Immucell Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
7
5
6
7
8
6
5
7
10
7
Gross Profit
2
1
1
2
3
2
2
2
4
2
Operating Income
0
-1
0
0
1
0
0
0
1
1
EBITDA
0
0
0
1
2
1
0
-2
2
2
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
-1
0
0
1
0
0
-2
1
1
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
0
-1
0
0
1
0
0
-2
1
1
Net Profit Margin
31.63%
22.48%
26.34%
36.53%
41.58%
43.72%
42.92%
38.16%
44.97%
33.92%

Immucell Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
10
10
13
15
19
18
17
26
27
Gross Profit
5
5
6
6
8
7
4
7
11
Operating Income
0
-1
0
-1
0
-2
-5
-1
1
EBITDA
0
0
1
1
2
0
-2
1
2
Interest Expense
0
0
0
0
0
0
0
0
0
Depreciation
0
1
2
2
2
2
2
2
2
Income Before Tax
0
-1
-1
-1
0
-2
-5
-2
-1
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
0
-2
-1
-1
0
-2
-5
-2
-1
Net Profit Margin
50.05%
47.28%
49.11%
44.73%
44.98%
41.19%
25.16%
29.97%
41.40%

Immucell Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
-1
0
0
1
0
0
-2
1
1
Operating Cash Flow
0
0
0
0
1
1
-1
0
3
3
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
3
0
0
0
0
0
0
0
Change in Cash
0
0
2
0
0
1
-2
0
3
2

Immucell Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-2
-1
-1
0
-2
-5
-2
-1
Operating Cash Flow
1
0
0
1
0
-1
-4
0
2
Investing Cash Flow
-12
-1
-3
-2
-1
-3
-1
0
-1
Financing Cash Flow
9
0
6
1
3
1
1
2
-1
Change in Cash
-1
-1
3
0
3
-4
-4
2
0

Global Institutional Holdings in Immucell

Check out the Institutions with significant holdings in Immucell.

Funds
Holdings
VANGUARD INDEX FUNDS
2.87%
Vanguard
2.86%
Fidelity Concord Street Trust
0.65%
DFA INVESTMENT DIMENSIONS GROUP INC
0.31%
iShares
0.22%
See all

Immucell News & Key Events

    Insights on Immucell

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, ICCC has outperformed top 5 stocks with highest market-cap in its industry

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 6 months, ICCC stock has moved up by 51.4%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 512.4%

    • imgNEGATIVE IMPACT

      Revenue Fall

      img

      Revenue is down for the last 2 quarters, 10.35M → 7.18M (in $), with an average decrease of 30.6% per quarter

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 2 quarters, 1.94M → 1.83M (in $), with an average decrease of 5.5% per quarter

    About Immucell

    ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and beef cattle, serving both the U.S. domestic market and international regions. Among its key products is First Defense, an orally administered preventative designed to combat scours in newborn dairy and beef calves. The company also provides Tri-Shield First Defense, a passive antibody treatment effective against E. coli, coronavirus, and rotavirus. Additionally, ImmuCell offers the California Mastitis Test, a diagnostic instrument used to quantify somatic cell counts in milk and identify which specific udder quarter may be affected by mastitis. Its Dual-Force First Defense product, incorporating a whey protein concentrate, caters to the nutritional and animal feed supplement industries. Currently under development is Re-Tain, a Nisin-based intramammary therapy targeting subclinical mastitis in lactating dairy cows. The company primarily distributes its products through a network of animal health distributors. ImmuCell Corporation was established in 1982 and is based in Portland, Maine.
    OrganisationImmucell
    Headquarters56 Evergreen Drive, Portland, ME, 04103, US
    IndustryBiotechnology
    CEOF. Olivier Te Boekhorst

    Key Management of Immucell

    Name

    Title

    Mr. Paul F. Olivier Te Boekhorst

    President, CEO & Director

    Mr. Timothy C. Fiori

    CFO, Secretary & Treasurer

    Ms. Bobbi Jo Brockmann

    Senior Vice President of Sales & Marketing

    Ms. Elizabeth S. Toothaker

    Director of Finance & Administration and Controller

    Mr. A. Gustavo Scaffa

    Senior Director of Quality

    John W. Zinckgraf

    Director of Product Development

    FAQs

    What is Immucell share price today?

    Immucell share price today is $9.75 as on at the close of the market. Immucell share today touched a day high of $9.80 and a low of $9.61.

    What is the 52 week high and 52 week low for Immucell share?

    Immucell share touched a 52 week high of $12.10 on and a 52 week low of $4.52 on . Immucell stock price today i.e. is closed at $9.75,which is 19.42% down from its 52 week high and 115.71% up from its 52 week low.

    What is Immucell's market capitalisation today?

    Immucell market capitalisation is $0.00T as on .

    How to invest in Immucell Stock (ICCC) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Immucell on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy Immucell Stock (ICCC) from India?

    Indian investors can start investing in Immucell (ICCC) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹963.00 in Immucell stock (as per the Rupee-Dollar exchange rate as on ). Based on Immucell share’s latest price of $9.75 as on October 3, 2026 at 8:46 am IST, you will get 1.0256 shares of Immucell. Learn more about fractional shares .

    What are the returns that Immucell has given to Indian investors in the last 5 years?

    Immucell stock has given 5.49% share price returns and 28.69% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?